72 results found.
4Q13/2013 Revenue: CONMED
4Q13 orthopaedic revenue: $107.7MM, +2% Sports Medicine/Tissue +3% Powered Instruments flat   2013 orthopaedic revenue: $410.2MM, +0.1% Healthcare utilization weaker than expected, hospital ...
BARE BONES® - October 24, 2013
CONMED reported 3Q13 orthopaedic surgery product sales of US $95.6MM, +0.8% from 3Q12. (
3Q13 Revenue: ConMed
Orthopaedic surgery products $95.6MM, +1% Procedure-specific and biologic products in sportsmed +8%, resection and fluid sportsmed products flat, powered instruments -5% Will preview a new 2-D system at AANA meeting, limited launch in 1Q14 Othe...
BARE BONES® - July 24, 2013
CONMED posted 2Q13 orthopaedic surgery product sales of US $101.8MM, -1.1% from 2Q12. (Growth reflects constant currency.) (CONMED Corporation, 7/24/13)
2Q13 Revenue: ConMed
Orthopaedic surgery product sales $101.8MM, -1% Sports Medicine -3% (Sports Biologics +4%) Powered Surgical -1%   Sports Med affected by foreign currency effects, government-imposed limits on procedures/spending in Euro...
BARE BONES® - April 25, 2013
CONMED posted 1Q13 orthopaedic surgery product sales of US $105MM, -1.1% from 1Q12. (Growth reflects constant currency.) (...
1Q13 Revenue: ConMed
$105MM, -2% (Sports Medicine -3%, Powered Surgical +1%) Noted that healthcare utilization seems flat in the U.S., despite modest job growth Revenue growth impacted by reduction in international healthcare spending, specifically major European countries ...
BARE BONES® - February 14, 2013
CONMED posted 2012 orthopaedic sales of US $480.5MM, +10% vs. 2011, and 4Q12 sales of $124.9MM, +12% vs. 4Q11. (2012 Arthroscopy $330.5MM, +14%; Powered Surgical Instruments $150.0MM, ...
4Q12 and 2012 Revenue: ConMed
$480.5MM, +10% (MTF partnership revenue $28MM) Arthroscopy $330.5MM, +14% Powered Surgical Instruments $150.0MM, +1% 4Q12 revenue: $124.9MM, +12% (MTF partnership revenue $7MM) Arthroscopy $86.6MM, +16%
3Q12 Earnings: ConMed
$112.7MM, +8% (Musculoskeletal Transplant Foundation $6.2MM) Arthroscopy $76.6MM, +10% (Single-use products +12%) Powered Instruments $36.1MM, +4%
BARE BONES® - October 25, 2012
CONMED reported 3Q12 orthopaedic sales of US $112.7MM, +8% from 3Q11. (Arthroscopy $76.6MM, +12%; Powered Instruments $36.1MM, +5%) Overall growth is ORTHOWORLD estimate. (
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - July 26, 2012
CONMED posted 2Q12 orthopaedic product sales of US $118.2MM, +9% from 2Q11. (Arthroscopy $81.0MM, +15%; Powered Instruments $37.2MM, -3%) (Growth reflects constant currency.) ...
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
BARE BONES® - April 26, 2012
CONMED posted 1Q12 orthopaedic product sales of US $124.8MM, +10% from 1Q11. (Arthroscopy $86.2MM, +14%; Powered Instruments $38.6MM, +0.8%) (Growth reflects constant currency...
Continuing 2011 Results, Including AAOS Conference Highlights
The orthopaedic industry appears to be tilting its focus from implant materials and toward implant alignment and personalization, per analyst review of the 2012 meeting of the American Academy of Orthopaedic Surgeons (AAOS). On the floor and in recent earnings calls, companies noted observatio...
BARE BONES® - February 15, 2012
CONMED posted 2011 orthopaedic sales of US $437.8MM, +
3Q11: A First Look at Financials: ConMed
CONMED $104.2MM, +1% * Arthroscopy $69.4MM, -1% (Single-use $54.4MM, +6%; Capital $15MM, -21%) * Powered Instruments $34.8MM, -2% (Single-use $18.7MM, -3%; Capital $16.1MM, -1%) * Sports med bolstered by new products (SRS Shoulder Repair, Se...
First Look at 2Q11 Results: ConMed
CONMED $108.9MM, -3% * Arthroscopy $70.6MM, -8% * Powered Instruments $38.3MM, +58%
First Look at 1Q11 Results: ConMed
CONMED $113.5MM, +6% * Arthroscopy $75.4MM, +5% (Single-use devices +6%, Capital equipment +10%) * Powered Instruments $38.1MM, +9% (Handpieces ~20%, Generators +15%, Video Systems flat)  *Global economic pressures will continue to impact gr...
Orthopaedic Sales Increases By Product Segment: 2010 vs. 2009

A First Look at 2010 Results: ConMed
CONMED $430.7MM, +4% * Arthroscopy $288.4MM, +5% * Powered Surgical Instruments $142.3MM, -3% * Expects single-use arthroscopy business will continue to lead growth as economy continues to improve * Not losing market share in su...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group